Calcuium citrate
Searched over 200M research papers for "calcuium citrate"
Summary
10 papers analyzed
These studies suggest that calcium citrate is more bioavailable than calcium carbonate when taken with a meal, while potassium citrate and other citrate treatments are effective in preventing and managing calcium oxalate kidney stones, reducing stone recurrence, and potentially improving cardiovascular function.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Calcium Citrate: Efficacy, Bioavailability, and Therapeutic Applications
Introduction to Calcium Citrate
Calcium citrate is a commonly used calcium supplement known for its high bioavailability and effectiveness in various medical applications. This article synthesizes research findings on calcium citrate, focusing on its role in preventing kidney stones, its bioavailability compared to other calcium supplements, and its broader therapeutic benefits.
Calcium Citrate in Kidney Stone Prevention
Potassium Citrate and Calcium Oxalate Stones
Potassium citrate, a compound related to calcium citrate, has been shown to significantly reduce the recurrence of calcium oxalate kidney stones. In a study involving patients who underwent shockwave lithotripsy (SWL) for lower pole calcium oxalate urolithiasis, those treated with potassium citrate had a 0% stone recurrence rate at 12 months, compared to a 28.5% recurrence rate in untreated patients. Additionally, potassium citrate therapy increased the remission rate of residual fragments post-SWL from 12.5% to 44.5%.
Potassium-Magnesium Citrate Efficacy
Another study demonstrated that potassium-magnesium citrate is highly effective in preventing recurrent calcium oxalate nephrolithiasis. Over a three-year period, new calculi formed in only 12.9% of subjects receiving potassium-magnesium citrate, compared to 63.6% in the placebo group, reducing the risk of recurrence by 85%.
Alkaline Citrate and Stone Regrowth
Alkaline citrate, which includes potassium-sodium citrate, has also been effective in reducing stone recurrence and growth post-ESWL and percutaneous nephrolithotomy (PCNL). At a 12-month follow-up, 92.3% of treated patients remained stone-free compared to 57.7% in the control group. This highlights the significant preventive effects of citrate-based therapies on calcium stone formation.
Bioavailability of Calcium Citrate
Comparison with Calcium Carbonate
Calcium citrate is more bioavailable than calcium carbonate, especially when taken with a meal. A study comparing the two supplements found that calcium citrate provided a 46% greater peak-basal variation and a 94% higher change in the area under the curve for serum calcium. Additionally, it resulted in a greater reduction in serum parathyroid hormone levels. This superior bioavailability makes calcium citrate a preferred choice for calcium supplementation, particularly in postmenopausal women.
Therapeutic Benefits of Citrate
Inhibition of Vascular Calcification
Citrate has been shown to attenuate vascular calcification in chronic renal failure (CRF) rats. Treatment with citrate reversed the accumulation of calcium in the aorta and reduced the activity of vascular calcification-related proteins in a dose-dependent manner. This suggests potential cardiovascular benefits of citrate in patients with CRF.
Citrate's Role in Crystallization and Stone Formation
Citrate inhibits the crystallization of stone-forming calcium salts, making it a crucial factor in preventing nephrolithiasis. It binds calcium, forming soluble complexes that reduce the saturation of calcium salts in urine . This mechanism underlies the therapeutic use of potassium citrate in managing various forms of kidney stones, including those associated with renal tubular acidosis and chronic diarrheal syndrome.
Conclusion
Calcium citrate and its related compounds, such as potassium citrate and potassium-magnesium citrate, play a vital role in preventing kidney stones and improving calcium bioavailability. Their therapeutic benefits extend beyond nephrolithiasis to potentially mitigating vascular calcification in chronic renal failure. These findings underscore the importance of citrate-based therapies in both clinical and preventive medicine.
Sources and full results
Most relevant research papers on this topic
